Summary by Moomoo AI
CRISPR Therapeutics officer Phuong Khanh Morrow is set to sell 50,767 shares of the company's common stock on 03/22/2024, as per the latest filings. The shares, valued at approximately $3,699,269.45, were acquired on the same date through the exercise of stock options. The transaction involved a cash payment to the issuer for the securities. This sale comes without any reported transactions by Morrow in the past three months.